Women’s Health

Guidance for the Diagnosis and Management of Ovarian Cysts

By

Meaghan Mize, PA-C

Alicia Elam, PharmD

The risk of developing benign ovarian cysts is up to 90% for premenopausal women and 75% for postmenopausal women.

Expectations for Involvement of Palliative Care Teams in Malignant Bowel Obstruction Vary Among Gynecologic Oncologists

By

Susan Moench, PhD, PA-C

Management of a malignant bowel obstruction in the setting of gynecologic cancer is complex and associated with multiple physical and psychosocial aspects of care.

Genetic Mutations ID’d in Breast Cancer After Menopause

3.55 percent of unselected postmenopausal women with breast cancer have pathogenic variants.

Social Support Linked to Mortality in Older Women With CRC

Low and moderate perceived social support linked to higher mortality in postmenopausal women with CRC.

U.S. Oncologist Shortage May Impact Women’s Health

Major U.S. cities are expected to have a shortage of oncologists.

Fewer Complications After MIRS Introduced for Endometrial Cancer

Introduction of minimally invasive robotic surgery linked to reduced complications among patients with early-stage endometrial cancer.

Pregnancy Screening During Chemotherapy

By

Lisa A. Thompson, PharmD, BCOP

What kind of pregnancy testing should be done in women of childbearing potential who are receiving chemotherapy?

Weight Loss May Cut Breast Cancer Risk in Postmenopausal Women

Researchers have linked weight loss with a lower risk of breast cancer in postmenopausal women.

Mortality Rates for Lung Cancer Likely to Surpass Breast Cancer Among Women by 2030

By

James Nam, PharmD

Screening practices and smoking habits are expected to have a significant impact on mortality rates for lung cancer and breast cancer among women in high-income countries.

Adding Trastuzumab to Uterine Serous Carcinoma Treatment Extended PFS

By

Jonathan Goodman, MPhil

Researchers explored whether adding trastuzumab to carboplatin and paclitaxel would improve survival outcomes for patients with advanced/recurrent disease with overexpressed HER2/neu.